Skip to main content
eXoZymes, Inc. (EXOZ)
NASDAQ: EXOZ · Real-Time Price · USD
15.50
+0.93 (6.38%)
At close: Sep 26, 2025, 4:00 PM EDT
15.69
+0.19 (1.23%)
After-hours: Sep 26, 2025, 4:10 PM EDT

eXoZymes Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
--0.07--
Other Revenue
---0.03-
Revenue
--0.070.03-
Revenue Growth (YoY)
--145.01%--
Gross Profit
--0.070.03-
Selling, General & Admin
5.364.061.340.980.84
Research & Development
2.731.870.530.380.45
Operating Expenses
8.095.931.871.361.29
Operating Income
-8.09-5.93-1.8-1.33-1.29
Interest & Investment Income
0.280.0800-
Other Non Operating Income (Expenses)
0.1-0.01-0.2--
EBT Excluding Unusual Items
-7.71-5.86-2-1.33-1.29
Other Unusual Items
----0.08
Pretax Income
-7.71-5.86-2-1.33-1.21
Income Tax Expense
-0-0.040.06-
Net Income
-7.71-5.86-2.04-1.4-1.21
Net Income to Common
-7.71-5.86-2.04-1.4-1.21
Shares Outstanding (Basic)
87665
Shares Outstanding (Diluted)
87665
Shares Change (YoY)
21.98%5.01%4.72%15.14%-
EPS (Basic)
-1.01-0.89-0.33-0.23-0.23
EPS (Diluted)
-1.01-0.89-0.33-0.23-0.23
Free Cash Flow
-9.21-8.9-1.47-1.44-2.01
Free Cash Flow Per Share
-1.21-1.36-0.23-0.24-0.39
Gross Margin
--100.00%100.00%-
Operating Margin
---2563.51%-4660.00%-
Profit Margin
---2909.12%-4881.91%-
Free Cash Flow Margin
---2097.34%-5046.08%-
EBITDA
-7.81-5.66-1.6-1.18-1.23
D&A For EBITDA
0.280.270.20.150.06
EBIT
-8.09-5.93-1.8-1.33-1.29
Revenue as Reported
---0.03-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q